Studies have shown that active fund managers routinely underperform the S&P500 index*​

Tenax Therapeutics, Inc. (NASDAQ: TENX)

TENX Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
195.60%

TENX Stock Analysis

TENX PE Ratio:

TENX PEG Ratio: Not Available

TENX Forward EPS Growth (12 month): 0.00%

TENX PS Ratio:

TENX PSG Ratio: Not Available

TENX Forward Revenue Growth (12 month): 0.00%

TENX Articles

No data was found